Summit Wealth Group (Colorado)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Summit Wealth Group (Colorado)'s ABBV Position: Q3 2026 in Review
Summit Wealth Group (Colorado) increased its AbbVie (ABBV) stake by 40% in Q3 2026, buying an estimated $326K and bringing the position to 4,437 shares worth $1.16M. The position accounts for 0.07% of the portfolio, ranked #150.
Summit Wealth Group (Colorado) first reported a position in ABBV in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.26M in Q3 2025. 4,257 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Summit Wealth Group (Colorado) held 4,437 shares of AbbVie worth $1.16M as of Q3 2026.
- Summit Wealth Group (Colorado) bought 1,272 AbbVie shares in Q3 2026, an estimated $326K.
- AbbVie made up 0.07% of Summit Wealth Group (Colorado)'s portfolio in Q3 2026, its #150 holding.
- Summit Wealth Group (Colorado) first reported a position in AbbVie in Q2 2025 and has held it in 6 quarters since.
- Summit Wealth Group (Colorado)'s AbbVie position peaked at $1.26M in Q3 2025.
- 4,257 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Summit Wealth Group (Colorado)'s 13F filing for Q3 2026, filed 29 Oct 2026.